MDR1/P-glycoprotein function. I. Effect of hypotonicity and inhibitors on rhodamine 123 exclusion

James L. Weaver, Leslie McKinney, Patricia V Schoenlein, Sarah Goldenberg, Michael M. Gottesman, Adorjan Aszalos

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The MDR1 protein (P-glycoprotein) is a membrane ATPase whose expression results in resistance to several anti-tumor drugs. It has been proposed that the MDR1 protein, in addition to its pumplike properties, can function as (Gill et al. Cell 71: 23-32, 1992; Altenberg et al. Cancer Res. 54: 618-622, 1994) or mediate the activity of (Hardy et al. EMBO J. 14: 68-75, 1995) a hypotonic stress-induced Cl- current. In addition, one study found that drug transport and Cl- channel-associated functions of MDR1 were separable and mutually exclusive and that, when cells were swelled, the MDR1 protein could not transport substrate. This hypothesis was tested in four pairs of isogenic cell lines with MDR1 transfectants expressing 8,000-55,000 MDR1 antibody binding sites per cell. Cytoplasmic exclusion of rhodamine 123 was used as an indicator of MDR1 function to measure the effect of hypotonic stress, MDR1 inhibitors, and Cl- channel blockers on MDR1 transport function. It was found that MDR1 activity and its inhibition by cyclosporine A or flufenamic acid were unaffected by hypotonicity alone or in combination with Cl- channel blockers.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Cell Physiology
Volume270
Issue number5 39-5
StatePublished - May 1 1996

Fingerprint

Rhodamine 123
P-Glycoprotein
Osmotic Pressure
Flufenamic Acid
Antibody Binding Sites
Pharmaceutical Preparations
Cyclosporine
Adenosine Triphosphatases
Neoplasms
Cell Line
Membranes

Keywords

  • 4,4'- diisothiocyanostilbene-2,2'-disulfonic acid
  • 4- acetamido-4'-isothiocyanostilbene-2,2'-disulfonic acid
  • chloride channel
  • cyclosporine A
  • drug efflux
  • flufenamic acid
  • multidrug resistance

ASJC Scopus subject areas

  • Physiology
  • Cell Biology

Cite this

MDR1/P-glycoprotein function. I. Effect of hypotonicity and inhibitors on rhodamine 123 exclusion. / Weaver, James L.; McKinney, Leslie; Schoenlein, Patricia V; Goldenberg, Sarah; Gottesman, Michael M.; Aszalos, Adorjan.

In: American Journal of Physiology - Cell Physiology, Vol. 270, No. 5 39-5, 01.05.1996.

Research output: Contribution to journalArticle

Weaver, James L. ; McKinney, Leslie ; Schoenlein, Patricia V ; Goldenberg, Sarah ; Gottesman, Michael M. ; Aszalos, Adorjan. / MDR1/P-glycoprotein function. I. Effect of hypotonicity and inhibitors on rhodamine 123 exclusion. In: American Journal of Physiology - Cell Physiology. 1996 ; Vol. 270, No. 5 39-5.
@article{7e535c69dc6f44e1bd81999a18882d90,
title = "MDR1/P-glycoprotein function. I. Effect of hypotonicity and inhibitors on rhodamine 123 exclusion",
abstract = "The MDR1 protein (P-glycoprotein) is a membrane ATPase whose expression results in resistance to several anti-tumor drugs. It has been proposed that the MDR1 protein, in addition to its pumplike properties, can function as (Gill et al. Cell 71: 23-32, 1992; Altenberg et al. Cancer Res. 54: 618-622, 1994) or mediate the activity of (Hardy et al. EMBO J. 14: 68-75, 1995) a hypotonic stress-induced Cl- current. In addition, one study found that drug transport and Cl- channel-associated functions of MDR1 were separable and mutually exclusive and that, when cells were swelled, the MDR1 protein could not transport substrate. This hypothesis was tested in four pairs of isogenic cell lines with MDR1 transfectants expressing 8,000-55,000 MDR1 antibody binding sites per cell. Cytoplasmic exclusion of rhodamine 123 was used as an indicator of MDR1 function to measure the effect of hypotonic stress, MDR1 inhibitors, and Cl- channel blockers on MDR1 transport function. It was found that MDR1 activity and its inhibition by cyclosporine A or flufenamic acid were unaffected by hypotonicity alone or in combination with Cl- channel blockers.",
keywords = "4,4'- diisothiocyanostilbene-2,2'-disulfonic acid, 4- acetamido-4'-isothiocyanostilbene-2,2'-disulfonic acid, chloride channel, cyclosporine A, drug efflux, flufenamic acid, multidrug resistance",
author = "Weaver, {James L.} and Leslie McKinney and Schoenlein, {Patricia V} and Sarah Goldenberg and Gottesman, {Michael M.} and Adorjan Aszalos",
year = "1996",
month = "5",
day = "1",
language = "English (US)",
volume = "270",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "5 39-5",

}

TY - JOUR

T1 - MDR1/P-glycoprotein function. I. Effect of hypotonicity and inhibitors on rhodamine 123 exclusion

AU - Weaver, James L.

AU - McKinney, Leslie

AU - Schoenlein, Patricia V

AU - Goldenberg, Sarah

AU - Gottesman, Michael M.

AU - Aszalos, Adorjan

PY - 1996/5/1

Y1 - 1996/5/1

N2 - The MDR1 protein (P-glycoprotein) is a membrane ATPase whose expression results in resistance to several anti-tumor drugs. It has been proposed that the MDR1 protein, in addition to its pumplike properties, can function as (Gill et al. Cell 71: 23-32, 1992; Altenberg et al. Cancer Res. 54: 618-622, 1994) or mediate the activity of (Hardy et al. EMBO J. 14: 68-75, 1995) a hypotonic stress-induced Cl- current. In addition, one study found that drug transport and Cl- channel-associated functions of MDR1 were separable and mutually exclusive and that, when cells were swelled, the MDR1 protein could not transport substrate. This hypothesis was tested in four pairs of isogenic cell lines with MDR1 transfectants expressing 8,000-55,000 MDR1 antibody binding sites per cell. Cytoplasmic exclusion of rhodamine 123 was used as an indicator of MDR1 function to measure the effect of hypotonic stress, MDR1 inhibitors, and Cl- channel blockers on MDR1 transport function. It was found that MDR1 activity and its inhibition by cyclosporine A or flufenamic acid were unaffected by hypotonicity alone or in combination with Cl- channel blockers.

AB - The MDR1 protein (P-glycoprotein) is a membrane ATPase whose expression results in resistance to several anti-tumor drugs. It has been proposed that the MDR1 protein, in addition to its pumplike properties, can function as (Gill et al. Cell 71: 23-32, 1992; Altenberg et al. Cancer Res. 54: 618-622, 1994) or mediate the activity of (Hardy et al. EMBO J. 14: 68-75, 1995) a hypotonic stress-induced Cl- current. In addition, one study found that drug transport and Cl- channel-associated functions of MDR1 were separable and mutually exclusive and that, when cells were swelled, the MDR1 protein could not transport substrate. This hypothesis was tested in four pairs of isogenic cell lines with MDR1 transfectants expressing 8,000-55,000 MDR1 antibody binding sites per cell. Cytoplasmic exclusion of rhodamine 123 was used as an indicator of MDR1 function to measure the effect of hypotonic stress, MDR1 inhibitors, and Cl- channel blockers on MDR1 transport function. It was found that MDR1 activity and its inhibition by cyclosporine A or flufenamic acid were unaffected by hypotonicity alone or in combination with Cl- channel blockers.

KW - 4,4'- diisothiocyanostilbene-2,2'-disulfonic acid

KW - 4- acetamido-4'-isothiocyanostilbene-2,2'-disulfonic acid

KW - chloride channel

KW - cyclosporine A

KW - drug efflux

KW - flufenamic acid

KW - multidrug resistance

UR - http://www.scopus.com/inward/record.url?scp=0030014951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030014951&partnerID=8YFLogxK

M3 - Article

C2 - 8967446

AN - SCOPUS:0030014951

VL - 270

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 5 39-5

ER -